A. Heppeler
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
- Neurology top 1%
- Neuroblastoma Research and Treatments
Papers in
- Epidemiology 11
- Neuroendocrine Tumor Research Advances 11
-
- Radiopharmaceutical Chemistry and Applications 7
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Helmut R. Mäcke (6 shared papers)Helmut R. Maëcke (5 shared papers)Jörg Schmitt (2 shared papers)Sandra Wenger (1 shared paper)Jean Claude Reubi (1 shared paper)Beatrice Waser (1 shared paper)Sylvie Froidevaux (6 shared papers)Martin Béhé (6 shared papers)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (4 papers)Chemistry - A European Journal (3 papers)International Journal of Cancer (1 paper)Regulatory Peptides (1 paper)Journal of the American Chemical Society (1 paper)
- Partner nations
- SwitzerlandPortugalGermany
In The Last Decade
A. Heppeler
13 papers receiving 2.5k citations
A. Heppeler's Hit Papers
Peers
Comparison fields: 5 of 75
- Radiology, Nuclear Medicine and Imaging 1.1k
- Neurology 685
- Epidemiology 1.5k
- Oncology 1.1k
- Endocrinology, Diabetes and Metabolism 134
Countries citing papers authored by A. Heppeler
This map shows the geographic impact of A. Heppeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Heppeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Heppeler more than expected).
Fields of papers citing papers by A. Heppeler
This network shows the impact of papers produced by A. Heppeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Heppeler. The network helps show where A. Heppeler may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Heppeler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use Hit paper breakdown → | 2000 | 906 |
| 2 | 2001 | 446 | |
| 3 | 1999 | 305 | |
| 4 | 1999 | 280 | |
| 5 | 2000 | 229 | |
| 6 | 1997 | 189 | |
| 7 | 2002 | 85 | |
| 8 | 2008 | 68 | |
| 9 | 2000 | 53 | |
| 10 | 1996 | 15 | |
| 11 | 1996 | 12 | |
| 12 | 1999 | 9 | |
| 13 | 2000 | 1 | |
| 14 | 2006 | 0 |
About A. Heppeler
A. Heppeler is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging, Neurology, Oncology and Spectroscopy, having authored 14 papers that have together received 2.6k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (11 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Lung Cancer Research Studies (6 papers), Neuroblastoma Research and Treatments (6 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Nanoplatforms for cancer theranostics (2 papers), Organoboron and organosilicon chemistry (1 paper) and Coordination Chemistry and Organometallics (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.1k citations), Neurology (685 citations), Epidemiology (1.5k citations), Oncology (1.1k citations) and Endocrinology, Diabetes and Metabolism (134 citations). A. Heppeler has collaborated with scholars based in Switzerland, Portugal and Germany. Frequent co-authors include Helmut R. Mäcke, Helmut R. Maëcke, Jörg Schmitt, Sandra Wenger, Jean Claude Reubi, Beatrice Waser, Sylvie Froidevaux, Martin Béhé, Alex N. Eberlé and E. Jermann. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Chemistry - A European Journal, International Journal of Cancer, Regulatory Peptides and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.